Eli Lilly CEO talks deal to cut medication prices with the Trump administration
PositiveU.S News

Eli Lilly's CEO, David Ricks, recently discussed a new agreement with the Trump administration aimed at reducing the prices of their weight loss drug, Zepbound. This deal is significant as it reflects a growing trend towards making essential medications more affordable for consumers, potentially improving access to treatment for many individuals struggling with weight management.
— via World Pulse Now AI Editorial System


